Dow Jones Top Company Headlines at 3 PM ET: GM, Toyota Hint at Tough Year Ahead for U.S. Auto Sales | U.S. ...
GM, Toyota Hint at Tough Year Ahead for U.S. Auto Sales
Sales are expected to slow after three years of gains as consumers push back on rising prices.
----
U.S. Companies Score Wins in Global Tax Deal
The Trump administration issued threats but stayed inside global talks-then bent them its way.
----
Chevron, Exxon and SLB Stocks Are Surging but Oil Prices Are Hardly Moving. What's Up.
Oil stocks were soaring early Monday even as crude prices were only up around 1% following the surprise U.S. operation to capture Venezuelan President Nicolás Maduro.
----
Wegovy Pill Now Broadly Available Across U.S.
Novo Nordisk's Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory approval, the Danish drugmaker said.
----
Universal Music to Buy Stake in India's Bollywood Movie Studio Excel for $90 Million
Universal Music Group will acquire a minority stake in Indian movie and digital content studio Excel Entertainment, boosting its presence in a market with high growth potential for recorded music.
----
QXO Gets a $1.2 Billion Apollo-Led Investment for M&A
Building-supplies company QXO, led by serial acquirer Brad Jacobs, landed a major investment to help fund future deals.
----
AT&T to Move HQ From Downtown Dallas to Suburb, Joining an Exodus From the Area
The telecom company's departure delivers another blow to one of the country's worst-hit central business districts.
----
Bed Bath & Beyond Names Exec Chairman Lemonis CEO
Bed Bath & Beyond appointed its executive chairman of the board Marcus Lemonis as its new chief executive. Lemonis was previously CEO of Camping World.
----
Defense Stocks Boosted by U.S. Intervention in Venezuela as Geopolitical Risk Rises
European defense companies jumped in early European trading after the U.S. ousted Venezuelan leader Nicolas Maduro, while U.S. peers are expected to also trade higher when the market opens.
----
Sanofi Says FDA Agrees to Review Diabetes Drug Age Range
The company said the regulator accepted a priority review to potentially expand the current age range for its Tzield type-1 diabetes drug to include children as young as one year old.
----
Tesla Stock Could Be Worth Just $80. The Price Is Rising.
A former Fidelity portfolio manager posted a valuation for Tesla on Saturday. It's low.
----
Comcast Spinoff Versant Starts Trading Today. The Stock Is Dropping.
The final separation of Comcast and Versant took place after Friday's close, completing a carve out first announced in November 2024.
----
Simulation or Not, Musk's Surreal Year Could Push Him to $1 Trillion Heights
Elon Musk could become the world's first trillionaire, even without his new Tesla pay package.
(END) Dow Jones Newswires
January 05, 2026 15:15 ET (20:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
This Once-Hot AI Stock Now Looks Deeply Undervalued
The 10 Best Companies to Invest in Now
He Tried Shorting Jim Cramer’s Stock Picks. It Cost Him More Than Money
United States